Athos Capital Ltd

Position in RVMD — Revolution Medicines, Inc.

CIK 1681662 HONG KONG, K3

Position in RVMD

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$3,588,525

New position

Shares Held

36,900

first reported quarter

Ownership

0.017%

of shares outstanding

% of Portfolio

1.17%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Athos Capital Ltd holds $22,540,765 across 4 Biotechnology names. RVMD ranks #3 (15.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	FOLD	AMICUS THERAPEUTICS, INC.	695,500	$10,056,930
2	ACLX	Arcellx, Inc.	64,900	$7,451,818
3	RVMD	Revolution Medicines, Inc. This page	36,900	$3,588,525
4	RNA	Atrium Therapeutics, Inc.	107,965	$1,443,492

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,588,525	36,900	—	Shares	Sole	2026-05-13
No filing history on record for this holder in this stock.